VisAR Augmented Reality Navigation of Ventriculostomy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDartmouth-Hitchcock Medical Center

About this trial

This study is intended to evaluate the feasibility of using VisAR augmented reality surgical navigation during placement of an external ventricular drain (EVD). The investigators are interested in confirming the design of the VisAR headset is compatible with this bedside procedure.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients, 18 years and older, determined to need an external ventricular drain (EVD) or ventriculostomy catheter by the attending neurosurgeon secondary to a variety of pathologies, including obstructive hydrocephalus, trauma and subarachnoid hemorrhage.

Disqualifiers

Patients less than 18 years of age.

Pregnant women.

Prisoners.

Trial design

Design model

Parallel

Treatments tested in this trial

  • VisAR

    Device

    The study device is a Microsoft HoloLens which uses Novarad's proprietary software and is collectively known as VisAR.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: VisAR NavigationExperimental treatment 1 intervention
Group B: Freehand NavigationNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Determining navigation system accuracy based on anatomical location and Kakarla scoring system.

The accuracy of VisAR in placement of EVDs primary assessment will be graded based on the anatomical location of the EVD, known as the Kakarla scoring system. The Kakarla scoring system has 3 grades of accuracy of placement based on the location of the catheter tip.

Time frame
During surgery

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: